Trials / Completed
CompletedNCT02095691
RENABLATE-II Feasibility Study of Catheter Based Renal Denervation to Treat Resistant Hypertension - 157
A Prospective, Multi-center, Non-Randomized, Feasibility Study of Catheter Based Renal Denervation to Treat Resistant Hypertension (RENABLATE-II - 157)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- Biosense Webster, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, multi-center, non-randomized, feasibility study to assess the safety and effectiveness of renal artery sympathetic denervation using the investigational devices in subjects with resistant hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Celsius® ThermoCool® Renal Denervation | The investigational device is indicated for the treatment of resistant hypertension by renal denervation. |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2014-03-01
- Completion
- 2015-04-01
- First posted
- 2014-03-26
- Last updated
- 2025-02-04
- Results posted
- 2015-12-07
Source: ClinicalTrials.gov record NCT02095691. Inclusion in this directory is not an endorsement.